Key Sildenafil Citrate Market Players:
- Pfizer Inc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Teva Pharmaceutical Industries Ltd
- Viatris Inc
- Aurobindo Pharma Ltd
- Sun Pharmaceutical Industries Ltd
- Cipla Ltd
- Sandoz International GmbH
- Dr. Reddy's Laboratories Ltd
- Lupin Ltd.
- Zydus Cadila
- Amneal Pharmaceuticals, Inc
- Alembic Pharmaceuticals Ltd
- Hikma Pharmaceuticals PLC
- Sanofi S.A
- Takeda Pharmaceutical Co. Ltd
- Aspen Pharmacare Holdings Ltd
- STADA Arzneimittel AG
- Mayne Pharma Group Ltd.
- Hanmi Pharmaceutical Co., Ltd
- Duopharma Biotech Berhad
The sildenafil citrate market is experiencing a gain in traction due to the intensifying competition between the global firms. The key trend that shaped the global market landscape is the expiration of Viagra’s patent, which dragged the interest of leading pharmaceutical firms to develop effective formulations. The domestic players in emerging nations are prioritizing affordable therapeutic production and enhanced distribution hubs to enhance their ecosystem in the global market. Furthermore, collaborations, acquisitions to expand the product portfolio also significantly contribute to the market expansion.
Below is the list of some prominent players operating in the sildenafil citrate market:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of sildenafil citrate is evaluated at USD 3.9 billion.
Sildenafil Citrate Market size was valued at USD 3.9 billion in 2025 and is projected to reach USD 6.7 billion by the end of 2035, rising at a CAGR of 5.7% during the forecast period, i.e., 2026 to 2035.
North America industry is anticipated to capture a significant share of 40.6% by 2035, attributable to the substantial consumer base and insurance coverage offered by public healthcare systems.
Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Cipla Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Lupin Limited, Dr. Reddy's Laboratories Ltd., Zydus Cadila, Sandoz (Novartis), Bayer AG, Eli Lilly and Company, Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals LLC, Apotex Inc., Hetero Drugs Ltd., Ajanta Pharma Ltd., Hikma, Pharmaceuticals, Centurion Laboratories, Yabang Pharma.
